update on durvalumab for metastatic bladder cancer
Published 7 years ago • 1K plays • Length 6:56Download video MP4
Download video MP3
Similar videos
-
2:03
durvalumab fda approval for bladder cancer
-
3:19
fda approval of durvalumab for advanced bladder cancer
-
4:38
danube trial: durvalumab alone or with tremelimumab for metastatic bladder cancer
-
1:07
dr. balar on impact of durvalumab plus tremelimumab in bladder cancer
-
1:00
dr. black on combinations with durvalumab in bladder cancer
-
1:33
dr. balar on results of durvalumab plus tremelimumab in bladder cancer
-
2:55
highlights of durvalumab for advanced bladder cancer
-
1:10
dr. powles discusses the future of durvalumab in bladder cancer
-
1:49
fda approval of durvalumab for bladder cancer
-
4:21
durvalumab for treatment of advanced bladder cancer
-
0:53
dr. siefker-radtke on fda approval of durvalumab in bladder cancer
-
4:17
metastatic bladder cancer: progression after maintenance
-
6:07
pacific trial: durvalumab following chemotherapy for stage iii nsclc
-
1:43
dr. sonpavde discusses a study of fixed-dose durvalumab and tremelimumab in urothelial carcinoma
-
1:05
dr. sonpavde on the role of durvalumab in platinum-refractory bladder cancer
-
3:32
updates on immunotherapy for bladder cancer
-
1:08
dr. rafii on durvaluamb in patients with urothelial bladder cancer
-
1:06
the mechanism of action of durvalumab in the treatment of urothelial bladder cancer
-
4:20
switch maintenance strategy for metastatic bladder cancer